HLVX
Price:
$1.9
Market Cap:
$94.59M
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
HLVX
According to HilleVax, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.14. This represents a change of -53.07% compared to the average of 10.95 of the last 4 quarters.
The mean historical Current Ratio of HilleVax, Inc. over the last ten years is 6.80. The current 5.14 Current Ratio has changed 7.45% with respect to the historical average. Over the past ten years (40 quarters), HLVX's Current Ratio was at its highest in in the September 2022 quarter at 34.77. The Current Ratio was at its lowest in in the March 2021 quarter at 0.
Average
6.80
Median
0.55
Minimum
0.15
Maximum
22.28
Discovering the peaks and valleys of HilleVax, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.97%
Maximum Annual Current Ratio = 22.28
Minimum Annual Increase = -61.67%
Minimum Annual Current Ratio = 0.15
Year | Current Ratio | Change |
---|---|---|
2023 | 10.62 | -52.34% |
2022 | 22.28 | 3.97% |
2021 | 0.55 | 255.41% |
2020 | 0.15 | -61.67% |
The current Current Ratio of HilleVax, Inc. (HLVX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.15
5-year avg
6.80
10-year avg
6.80
HilleVax, Inc.’s Current Ratio is less than PMV Pharmaceuticals, Inc. (19.22), less than Eliem Therapeutics, Inc. (60.41), less than MediciNova, Inc. (18.24), less than Pharvaris N.V. (18.45), less than PepGen Inc. (7.45), less than Molecular Partners AG (14.58), less than Monte Rosa Therapeutics, Inc. (6.56), less than Entrada Therapeutics, Inc. (5.70), less than Vigil Neuroscience, Inc. (8.39), less than Century Therapeutics, Inc. (10.62), less than Edgewise Therapeutics, Inc. (30.24), less than C4 Therapeutics, Inc. (6.31), less than Mineralys Therapeutics, Inc. (11.20), less than Cullinan Oncology, Inc. (28.87), less than Pardes Biosciences, Inc. (81.72), less than Shattuck Labs, Inc. (7.62), greater than Champions Oncology, Inc. (0.69), less than NewAmsterdam Pharma Company N.V. (9.83), less than Centessa Pharmaceuticals plc (13.29), greater than Sutro Biopharma, Inc. (3.41), greater than Opthea Limited (2.94),
Company | Current Ratio | Market cap |
---|---|---|
19.22 | $84.49M | |
60.41 | $342.68M | |
18.24 | $82.40M | |
18.45 | $1.29B | |
7.45 | $221.28M | |
14.58 | $247.30M | |
6.56 | $542.54M | |
5.70 | $661.04M | |
8.39 | $153.44M | |
10.62 | $106.74M | |
30.24 | $3.23B | |
6.31 | $455.30M | |
11.20 | $671.31M | |
28.87 | $922.99M | |
81.72 | $135.19M | |
7.62 | $55.36M | |
0.69 | $57.64M | |
9.83 | $1.96B | |
13.29 | $1.80B | |
3.41 | $302.45M | |
2.94 | $628.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HilleVax, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HilleVax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is HilleVax, Inc.'s Current Ratio?
How is the Current Ratio calculated for HilleVax, Inc. (HLVX)?
What is the highest Current Ratio for HilleVax, Inc. (HLVX)?
What is the 3-year average Current Ratio for HilleVax, Inc. (HLVX)?
What is the 5-year average Current Ratio for HilleVax, Inc. (HLVX)?
How does the current Current Ratio for HilleVax, Inc. (HLVX) compare to its historical average?